Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred? (Q82954051)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Olivier Chinot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Luc Taillandier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Monica Sierra Del Rio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Charlotte Carnin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Marylin Barrie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Carole Soussain

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Marie-Laure Tanguy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sylvain Choquet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Veronique Leblond

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Khe Hoang-Xuan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

ANOCEF Group (French Neuro-Oncology Association)

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

19 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

323-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21170569%20AND%20SRC:MED&resulttype=core&format=json

Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study

18 January 2020

cites work

1 reference

12 December 2020

Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.

1 reference

12 December 2020

High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study

1 reference

12 December 2020

Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.

1 reference

12 December 2020

Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience

1 reference

12 December 2020

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

1 reference

12 December 2020

Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma

1 reference

12 December 2020

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

1 reference

12 December 2020

Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma

1 reference

12 December 2020

NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report

1 reference

12 December 2020

High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system

1 reference

12 December 2020

Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

1 reference

12 December 2020

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

1 reference

12 December 2020

Delayed neurotoxicity in primary central nervous system lymphoma

1 reference

12 December 2020

Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.

1 reference

12 December 2020

Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma

1 reference

12 December 2020

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function

1 reference

12 December 2020

High-dose methotrexate for elderly patients with primary CNS lymphoma

1 reference

12 December 2020

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

1 reference

12 December 2020

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

1 reference

12 December 2020

Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma

1 reference

12 December 2020

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

1 reference

12 December 2020

High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma

1 reference

12 December 2020

Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

1 reference

12 December 2020

Chemotherapy for primary central nervous system lymphoma

1 reference

12 December 2020

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly

1 reference

12 December 2020

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

1 reference

12 December 2020

Radiation-induced dementia in patients cured of brain metastases

1 reference

12 December 2020

Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments

1 reference

12 December 2020

Treatment for primary CNS lymphoma: the next step

1 reference

12 December 2020

CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma

1 reference

12 December 2020

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

1 reference

12 December 2020

The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression

1 reference

12 December 2020

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

1 reference

12 December 2020

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma

1 reference

12 December 2020

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis

1 reference

12 December 2020

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

1 reference

12 December 2020